FilingReader Intelligence
Gland Pharma announces ₹18 final dividend
July 31, 2025 at 07:59 AM UTC•By FilingReader AI
Gland Pharma Limited announced a final dividend of ₹18 per equity share for the financial year ended March 31, 2025.
The company reported consolidated revenue of ₹56,165 million and EBITDA of ₹12,689 million for FY 2024-25. Total R&D expenditure was ₹1,922 million.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:GLAND•Bombay Stock Exchange
News Alerts
Get instant email alerts when Gland Pharma publishes news
Free account required • Unsubscribe anytime